Riverview Trust Company’s NEVRO CORP. NVRO Stock Holding History

Riverview Trust Company’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-292	Closed	-$14K	–	885
2022 Q3	$14K	Hold	292	–	–	0.01%	485
2022 Q2	$13K	Buy	+292	New	+$16.1K	0.01%	602

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverview Trust Company's NVRO Position: Q4 2022 in Review

Riverview Trust Company sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 292 shares — an estimated $14K sold.

Riverview Trust Company first reported a position in NVRO in Q2 2022 and held it in 2 quarters. The position peaked at $14K in Q3 2022. 170 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

Riverview Trust Company reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
Riverview Trust Company sold 292 NEVRO CORP. shares in Q4 2022, an estimated $14K.
Riverview Trust Company first reported a position in NEVRO CORP. in Q2 2022 and held it in 2 quarters.
Riverview Trust Company's NEVRO CORP. position peaked at $14K in Q3 2022.
170 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on Riverview Trust Company's 13F filing for Q4 2022, filed 26 Jan 2023.